Included In Bausch’s Planned Spin-Off, Consumer Brands Account For 3 Spots In Its Top 10 List

 
• By Malcolm Spicer

Sales of its segment leaders Ocuvite and PreserVision vision health supplements, Lumify OTC eye drops and other consumer lines were down a reported 13% to $321m in the second quarter.

Bausch Ocuvite nd Perservision
The Ocuvite and PreserVision lines make up Bausch's No. 3 seller overall and, along with its other consumer health brands, will be included in its planned Bausch + Lomb spin-off.

More from Business

More from Wellness